Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-015190
Filing Date
2018-03-27
Accepted
2018-03-27 14:38:19
Documents
2
Period of Report
2018-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1662
2 POWER OF ATTORNEY poa_lundberg.htm EX-24.1 8648
  Complete submission text file 0001140361-18-015190.txt   11684
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Lundberg Jan M (Reporting) CIK: 0001480120 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36485 | Film No.: 18715066